hepatitis C treatment
Scope
Date
~
-
Construction & Planning
Samsung C&T-UEM completes world's 2nd-tallest skyscraper in Malaysia
South Korea’s Samsung C&T Corp. announced on Thursday that its JV with UEM Construction completed the construction of the world's second t...
Jan 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...
Jan 10, 2024 (Gmt+09:00)
-
Construction
Ssangyong E&C wins $57 million deal to build solar cell plant in Haiti
South Korea’s Ssangyong Engineering & Construction Co. (Ssangyong E&C) said on Tuesday it has won a $57 million deal to build a 12-meg...
Jan 09, 2024 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab, Yuhan to co-work for obesity treatment
South Korea’s Inventage Lab Inc. announced on Friday that it has signed a joint development agreement with Yuhan Corp. for a long-acting inj...
Jan 05, 2024 (Gmt+09:00)
-
Energy
KEPCO sells 15% stake in KEPCO E&C for $269 million
Korea Electric Power Corp. (KEPCO), South Korea’s state-owned utility company grappling with mounting losses, has secured additional funds of ...
Jan 02, 2024 (Gmt+09:00)
-
Construction & Planning
Daewoo E&C opens theme park Ice Jungle in Phu Quoc
South Korea's Daewoo Engineering & Construction Co. (Daewoo E&C) opened the digital theme park Ice Jungle in its ongoing luxury residential ...
Dec 29, 2023 (Gmt+09:00)
-
Bio & Pharma
ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe
ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval of Xolair biosimilar in Canada
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...
Dec 27, 2023 (Gmt+09:00)
-
Construction
SGC eTEC E&C wins $160 mn plant order in Malaysia
South Korea's SGC eTEC E&C Co. said on Tuesday it has won a 204.7 billion won ($158 million) order to build epichlorohydrin (ECH) and chlor-alka...
Dec 26, 2023 (Gmt+09:00)
-
Construction
DL E&C’s 1915 Çanakkale Bridge named Project of the Year
South Korea’s DL E&C Co. announced on Wednesday that 1915 Çanakkale Bridge in Türkiye, completed by the company, received th...
Dec 20, 2023 (Gmt+09:00)
-
Electric vehicles
Shinsegae I&C to open charging station Spharos EV
South Korea’s Shinsegae I&C Inc. announced on Monday that its electric vehicle (EV) charging service Spharos EV will introduce a total o...
Dec 18, 2023 (Gmt+09:00)
-
Bio & Pharma
ToolGen gets FDA approval for TGT-001 as ODD
South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...
Dec 18, 2023 (Gmt+09:00)
-
Carbon neutrality
Samsung C&T to join Oman's green ammonia project
South Korea’s Samsung C&T Corp. announced on Wednesday it will participate in the Salalah H2 green ammonia project in Oman, a major init...
Dec 13, 2023 (Gmt+09:00)
-
Petrochemicals
DL E&C, KBR to co-work for SAF project
South Korea’s DL E&C Co. announced on Wednesday that it signed a feasibility study contract with Kellogg Brown & Root (KBR) Inc., the ...
Dec 13, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s GC Cell targets global cell therapy CDMO business
GC Cell Corp., an affiliate of South Korea’s major pharmaceutical company GC Biopharma Corp., is targeting the cell therapy contract developme...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Chemical Industry
Samyang launches industrial water treatment products
South Korean chemical and food company Samyang Corp. announced on Monday that it released new industrial water treatment materials Triraite Reverse ...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
-
Shareholder activism
Palliser Capital urges Samsung C&T reform for $25 bn value-up
London-based hedge fund Palliser Capital said on Wednesday that Samsung C&T Corp. is 63% intrinsically undervalued and could increase its value ...
Dec 07, 2023 (Gmt+09:00)
-
Construction
Korean Daewoo E&C seeks biz amid Indonesia’s new capital plan
South Korean Daewoo Engineering & Construction Co. is seeking business opportunities alongside Indonesia’s plan to relocate its capital as...
Dec 05, 2023 (Gmt+09:00)
-
Aerospace & Defense
S.Korea to buy more F-35As, but picks Embraer C-390s for transport
South Korea has chosen the F-35A by US-based Lockheed Martin Aeronautics as its stealth aircraft and Brazil-headquartered aerospace company Embraer&...
Dec 04, 2023 (Gmt+09:00)
-
Central bank
BOK chief says rates need to stay high for over 6 months
South Korea’s central bank chief on Thursday said interest rates will have to stay high for more than six months, leaving the door open for an...
Nov 30, 2023 (Gmt+09:00)
-
Blockchain
SK C&C to build Hana Securities STO system
South Korea's SK C&C announced on Tuesday that it will supply its blockchain service platform ChainZ Security Token (ChainZ ST) to build the sys...
Nov 28, 2023 (Gmt+09:00)
-
Construction
Daewoo E&C seeks energy infrastructure biz in Yemen
South Korea's Daewoo Engineering & Construction Co. announced on Friday that it signed a memorandum of understanding (MOU) with the Yemeni Minis...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK C&C to promote AI healthcare for brain diseases
South Korea's SK C&C announced on Thursday that it signed a strategic business agreement with Neurophet, a cloud-based AI platform for brain ima...
Nov 23, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Nov 13, 2023 (Gmt+09:00)
-
Hydrogen economy
Samsung C&T to build world’s largest liquid hydrogen tank
South Korea's Samsung C&T Corp. announced on Sunday it received certification for the world's largest liquid hydrogen storage tank design from D...
Nov 13, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharma’s Cenobamate US patent extended by 2032
South Korea's SK Biopharmaceuticals announced on Friday an extension of its US patent for the epilepsy treatment Cenobamate, now set to expire on Oc...
Nov 10, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand